BioHelix Corp.
Biotechnology ResearchUnited States2-10 Employees
BioHelix Corp. operates in the biotechnology research sector, focused on developing simple molecular diagnostic tests intended for near-patient use where rapid results are critical. Its IsoAmp assays combine proprietary isothermal amplification technology with a detection device that does not require instruments, aiming to provide flexible, low-capital solutions for molecular testing across clinical laboratories. The company targets middle-tier hospital labs, point-of-care settings, and, in the longer term, advancements toward personalized medicine, supported by ongoing R&D and partnerships with industry players. Based in the United States, BioHelix positions itself as enabling accessible molecular diagnostics through streamlined workflows and cost-effective options. In August 2021, BioHelix became part of a broader corporate consolidation through the acquisition activity involving Quidel Corporation, reflecting activity in the broader diagnostics landscape.
1-888-653-2347 
support@leadiq.com 
